Subjects were included in the completion condition
RECRUITMENT
From February to April in 2023, 64 subjects were recruited for this study, with 60 subjects identified as "positive" by OMOST after excluding 4 subjects who did not meet the inclusion criteria. These subjects were randomly allocated to 24TCCG, TCKFFG, TCSBG, and CG, each consisting of 15 cases. A total of 49 cases completed the trial after staff communication and consultation, with 11 cases lost. 24TCCG had 13 cases (86.7% compliance), TCKFFG had 12 patients (80% compliance), TCSBG had 11 patients (73.3% compliance), and CG had 13 patients (86.7% compliance). Details of the subject recruitment process are presented in Fig. Flow program for detailed recruitment selection of subjects